Search Results - "Ezponda, Teresa"

Refine Results
  1. 1

    Molecular pathways: deregulation of histone h3 lysine 27 methylation in cancer-different paths, same destination by Ezponda, Teresa, Licht, Jonathan D

    Published in Clinical cancer research (01-10-2014)
    “…Methylation of lysine 27 on histone H3 (H3K27me), a modification associated with gene repression, plays a critical role in regulating the expression of genes…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Alternative splicing: an emerging topic in molecular and clinical oncology by Pajares, María J, PhD, Ezponda, Teresa, MSc, Catena, Raúl, MSc, Calvo, Alfonso, PhD, Pio, Ruben, Prof, Montuenga, Luis M, Prof

    Published in The lancet oncology (01-04-2007)
    “…Summary Alternative pre-mRNA splicing is a key molecular event that allows for protein diversity. Through this process, a single gene increases its coding…”
    Get full text
    Journal Article
  10. 10

    SimiC enables the inference of complex gene regulatory dynamics across cell phenotypes by Peng, Jianhao, Serrano, Guillermo, Traniello, Ian M., Calleja-Cervantes, Maria E., Chembazhi, Ullas V., Bangru, Sushant, Ezponda, Teresa, Rodriguez-Madoz, Juan Roberto, Kalsotra, Auinash, Prosper, Felipe, Ochoa, Idoia, Hernaez, Mikel

    Published in Communications biology (12-04-2022)
    “…Single-cell RNA-Sequencing has the potential to provide deep biological insights by revealing complex regulatory interactions across diverse cell phenotypes at…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Deregulation of the Ras-Erk Signaling Axis Modulates the Enhancer Landscape by Nabet, Behnam, Ó Broin, Pilib, Reyes, Jaime M., Shieh, Kevin, Lin, Charles Y., Will, Christine M., Popovic, Relja, Ezponda, Teresa, Bradner, James E., Golden, Aaron A., Licht, Jonathan D.

    Published in Cell reports (Cambridge) (25-08-2015)
    “…Unrestrained receptor tyrosine kinase (RTK) signaling and epigenetic deregulation are root causes of tumorigenesis. We establish linkage between these…”
    Get full text
    Journal Article
  13. 13

    The Oncoprotein SF2/ASF Promotes Non-Small Cell Lung Cancer Survival by Enhancing Survivin Expression by EZPONDA, Teresa, PAJARES, Maria J, AGORRETA, Jackeline, ECHEVESTE, José I, LOPEZ-PICAZO, José M, TORRE, Wenceslao, PIO, Ruben, MONTUENGA, Luis M

    Published in Clinical cancer research (15-08-2010)
    “…SF2/ASF is a splicing factor recently described as an oncoprotein. In the present work, we examined the role of SF2/ASF in human non-small cell lung cancer…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Mitochondria Are Required for Antigen-Specific T Cell Activation through Reactive Oxygen Species Signaling by Sena, Laura A., Li, Sha, Jairaman, Amit, Prakriya, Murali, Ezponda, Teresa, Hildeman, David A., Wang, Chyung-Ru, Schumacker, Paul T., Licht, Jonathan D., Perlman, Harris, Bryce, Paul J., Chandel, Navdeep S.

    Published in Immunity (Cambridge, Mass.) (21-02-2013)
    “…It is widely appreciated that T cells increase glycolytic flux during activation, but the role of mitochondrial flux is unclear. Here, we have shown that…”
    Get full text
    Journal Article
  16. 16

    Molecular Pathways: Deregulation of Histone 3 Lysine 27 Methylation in Cancer—Different Paths, Same Destination by Ezponda, Teresa, Licht, Jonathan D.

    Published in Clinical cancer research (01-07-2014)
    “…Methylation of lysine 27 on histone 3 (H3K27me), a modification associated with gene repression, plays a critical role in regulating the expression of genes…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents by Shah, M Y, Martinez-Garcia, E, Phillip, J M, Chambliss, A B, Popovic, R, Ezponda, T, Small, E C, Will, C, Phillip, M P, Neri, P, Bahlis, N J, Wirtz, D, Licht, J D

    Published in Oncogene (10-11-2016)
    “…MMSET/WHSC1 is a histone methyltransferase (HMT) overexpressed in t(4;14)+ multiple myeloma (MM) patients, believed to be the driving factor in the…”
    Get full text
    Journal Article